CureVac(CVAC) - 2023 Q1 - Quarterly Report

Exhibit 99.1 Unaudited Interim Condensed Consolidated Financial Statements CureVac N.V. | --- | --- | --- | --- | |---------------------------------------------------------------|-------|---------------------------------------|----------------------------| | (in thousands of EUR, except per share amounts) | Note | Three months \n2022 (unaudited) | ended March 31, \n2023 | | Revenue | 3.1 | 24,373 | 7,129 | | Cost of sales | 3.2 | (37,232) | (20,634) | | Selling and distribution expenses | 3.3 | (271) | (824 ...